🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Michael Webster‐Clark

Wake Forest University

ORCID: 0000-0002-8079-8504
MathematicsEconomics, Econometrics and FinanceMedicineDecision Sciences

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

0in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 15 papers. Top paper: “Real‐world on‐treatment and initial treatment absolute risk differences for dabigatran vs warfarin in older US adults”.

Real‐world on‐treatment and initial treatment absolute risk differences for dabigatran vs warfarin in older US adults

Pharmacoepidemiology and Drug Safety(2020)10.1002/pds.5069
N/A
0DataRank · unranked
7 citations

Til Stürmer‎, Jessie K. Edwards, Charles Poole, Ross J. Simpson, Jennifer L. Lund +1 more

Assessing clinical trial effects on outcomes among pediatric and adolescent and young adult (AYA) patients with cancer

Cancer(2020)10.1002/cncr.33252
N/A
0DataRank · unranked
0 citations

Jeff Y. Yang, Sydney Thai, Michael Webster‐Clark, Jennifer L. Lund, Shahar Shmuel

Propensity Score Weighting and Trimming Strategies for Reducing Variance and Bias of Treatment Effect Estimates: A Simulation Study

American Journal of Epidemiology(2021)10.1093/aje/kwab041
N/A
0DataRank · unranked
116 citations

Michael Webster‐Clark, Jennifer L. Lund, Richard Wyss, Alan R. Ellis, Mark Lunt +3 more

The Timing, the Treatment, the Question: Comparison of Epidemiologic Approaches to Minimize Immortal Time Bias in Real-World Data Using a Surgical Oncology Example

Cancer Epidemiology Biomarkers & Prevention(2022)10.1158/1055-9965.epi-22-0495
N/A
0DataRank · unranked
43 citations

Bradford E. Jackson, Michael Webster‐Clark, Jennifer L. Lund, Katherine E. Reeder‐Hayes, Anna María Nápoles +2 more

Alternative analytic and matching approaches for the prevalent new‐user design: A simulation study

Pharmacoepidemiology and Drug Safety(2022)10.1002/pds.5446
N/A
0DataRank · unranked
7 citations

Panagiotis Mavros, Elizabeth M. Garry, Til Stürmer‎, Shahar Shmuel, Jessica C. Young +2 more

A systematic review of whether COVID‐19 randomized controlled trials reported on demographic and clinical characteristics

Pharmacoepidemiology and Drug Safety(2022)10.1002/pds.5533
N/A
0DataRank · unranked
1 citations

Jennifer L. Lund, Alexander P. Keil, Daniel Westreich, Til Stürmer‎, David A. Wohl +4 more

Real-world on-treatment and initial treatment absolute risk differences for dabigatran vs warfarin in older US adults

UNC Libraries(2023)10.17615/73te-re77
N/A
0DataRank · unranked
2 citations

J.K. Edwards, J.L. Lund, Michael Webster‐Clark, T. Stürmer, Charles Poole +1 more

Core Concepts in Pharmacoepidemiology: New‐User Designs

Pharmacoepidemiology and Drug Safety(2024)10.1002/pds.70048
N/A
0DataRank · unranked
26 citations

Julie Rouette, Jessica C. Young, Michael Webster‐Clark, John Tazare, Qoua L. Her

Variable selection when estimating effects in external target populations

American Journal of Epidemiology(2024)10.1093/aje/kwae048
N/A
0DataRank · unranked
6 citations

Rachael K. Ross, Alexander P. Keil, Robert W. Platt, Michael Webster‐Clark

Improving subgroup analysis using methods to extend inferences to specific target populations

arXiv (Cornell University)(2024)10.48550/arxiv.2406.08297
N/A
0DataRank · unranked
0 citations

Anthony A. Matthews, Alan R. Ellis, Alan C. Kinlaw, Robert W. Platt, Michael Webster‐Clark

The Timing, the Treatment, the Question: Comparison of Epidemiologic Approaches to Minimize Immortal Time Bias in Real-World Data Using a Surgical Oncology Example

UNC Libraries(2024)10.17615/zawz-2b55
N/A
0DataRank · unranked
0 citations

J.L. Lund, Paula D. Strassle, Anna María Nápoles, K.E. Reeder-Hayes, E.D. Duchesneau +2 more

Assessing clinical trial effects on outcomes among pediatric and adolescent and young adult (AYA) patients with cancer

UNC Libraries(2024)10.17615/7ksn-p096
N/A
0DataRank · unranked
0 citations

S. Thai, Michael Webster‐Clark, Jing Yang, Shahar Shmuel, Jennifer L. Lund

Target Validity: Bringing Treatment of External Validity in Line with Internal Validity

UNC Libraries(2024)10.17615/5sz2-jz80
N/A
0DataRank · unranked
0 citations

Catherine R. Lesko, Benjamin Ackerman, Jessie K. Edwards, Michael Webster‐Clark

Variable selection when estimating effects in external target populations

UNC Libraries(2024)10.17615/pyc8-pc95
N/A
0DataRank · unranked
0 citations

Alexander P. Keil, Michael Webster‐Clark, Rachael K. Ross, Robert W. Platt

Core Concepts in Pharmacoepidemiology: New‐User Designs

UNC Libraries(2024)10.17615/hrb1-9y22
N/A
0DataRank · unranked
0 citations

Michael Webster‐Clark, Qoua L. Her, John Tazare, Julie Rouette, Jessica C. Young